Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel

Published:2021-08-02 Issue:11 Volume:28 Page:3742-3748
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Euro J of Neurology

Author:

Lotan Itay¹²³^ORCID,Wilf‐Yarkoni Adi¹²³,Friedman Yitzhak¹²³,Stiebel‐Kalish Hadas³⁴,Steiner Israel¹³,Hellmann Mark A.¹²³

Affiliation:

1. Department of Neurology Rabin Medical Center Petah Tikva Israel

2. Neuroimmunology Unit Rabin Medical Center Petah Tikva Israel

3. Sackler Faculty of Medicine Tel‐Aviv University Israel

4. Department of Ophthalmology and Neuro‐Ophthalmology Unit Rabin Medical Center Petah Tikva Israel

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.15028

Reference34 articles.

1. A Guide to COVID‐19: a global pandemic caused by the novel coronavirus SARS‐CoV‐2

2. Coronaviridae

3. WHO declares COVID‐19 a pandemic;Cucinotta D;Acta Biomed,2020

4. COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies

5. SARS-CoV-2 vaccine candidates in rapid development

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders;Vaccine;2024-10

2. The effect of COVID‐19 vaccination on multiple sclerosis activity as reflected by MRI;Brain and Behavior;2024-06-28

3. Vaccination status and self-reported side effects after SARS-CoV-2 vaccination in relation to psychological and clinical variables in patients with multiple sclerosis;Scientific Reports;2024-05-28

4. Impact of COVID-19 on Health Status and Management of Patients with CNS Demyelinating Diseases: A Single-Center Study;Siriraj Medical Journal;2024-03-01

5. A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study;Human Vaccines & Immunotherapeutics;2024-02-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3